Sleep Apnea Oral Appliances Market 2023: Investigating Research Trends, Industry Expansion, and Projections for 2028
In 2023, Vivos Therapeutics, Inc. (US) DNA appliance was granted 510(k) clearance from the U.S. Food & Drug Administration (or FDA) as a Class II medical device in December 2022 for the treatment of snoring and mild to moderate OSA in adults.
View full press release